There’s something to be said for experience, and we’ve got a lot of it. Since 1999, Siren has been paving the way in the rare disease space. We’ve helped clients make their first social media forays, and we’ve launched more orphan drugs than any other marketing agency.
Tackling the needs of the rare disease community is a tall order, but our clients are up to the task. As a company that is passionately focused on orphan drug marketing, we share a common vision with the companies with whom we work.
Every disorder should have a treatment, no matter how rare or how complex it is. From hemophilia to Huntington’s disease to hypoparathyroidism, we’re taking rare diseases on head to head. For more than 15 years, across more than 30 disease states we’ve had 1 focus—rare disease marketing.
Our central hub of rare disease information, the Rare Opportunities Platform™ contains data on a wide range of rare disorders. Using the database, we can survey the landscape of a given disease state, from available treatment options to relevant patient organizations and more. When we have a comprehensive understanding of the disease state, we then perform predictive analysis to determine which marketing tactics are most likely to meet the needs of the patient community and meet our client’s goals for success.